- Home
- DCGO vs TKNO Comparison
DCGO vs TKNO Comparison
Compare DCGO & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCGO
- TKNO
- Stock Information
- Founded
- DCGO 2015
- TKNO 1996
- Country
- DCGO United States
- TKNO United States
- Employees
- DCGO N/A
- TKNO N/A
- Industry
- DCGO Managed Health Care
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- DCGO Health Care
- TKNO Health Care
- Exchange
- DCGO Nasdaq
- TKNO Nasdaq
- Market Cap
- DCGO 503.6M
- TKNO 430.2M
- IPO Year
- DCGO N/A
- TKNO 2021
- Fundamental
- Price
- DCGO $4.79
- TKNO $7.45
- Analyst Decision
- DCGO Strong Buy
- TKNO Buy
- Analyst Count
- DCGO 5
- TKNO 2
- Target Price
- DCGO $6.10
- TKNO $5.00
- AVG Volume (30 Days)
- DCGO 702.8K
- TKNO 266.7K
- Earning Date
- DCGO 02-27-2025
- TKNO 03-04-2025
- Dividend Yield
- DCGO N/A
- TKNO N/A
- EPS Growth
- DCGO 300.38
- TKNO N/A
- EPS
- DCGO 0.29
- TKNO N/A
- Revenue
- DCGO $694,968,328.00
- TKNO $36,347,000.00
- Revenue This Year
- DCGO $2.14
- TKNO $3.47
- Revenue Next Year
- DCGO N/A
- TKNO $12.07
- P/E Ratio
- DCGO $16.79
- TKNO N/A
- Revenue Growth
- DCGO 30.19
- TKNO N/A
- 52 Week Low
- DCGO $2.75
- TKNO $1.16
- 52 Week High
- DCGO $5.68
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- DCGO 45.48
- TKNO 38.57
- Support Level
- DCGO $5.25
- TKNO $7.76
- Resistance Level
- DCGO $5.68
- TKNO $8.45
- Average True Range (ATR)
- DCGO 0.24
- TKNO 0.62
- MACD
- DCGO -0.04
- TKNO -0.19
- Stochastic Oscillator
- DCGO 9.23
- TKNO 0.00
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company has three reportable segments: Mobile Health Services, Transportation Services, and Corporate. Mobile Health Services is the key revenue-generating segment for the company.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.